Total Assets (Quarterly) Chart

View Total Assets (Quarterly) for PRGO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Assets (Quarterly) Chart
Start Trial

Historical Total Assets (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 7.610B
March 31, 2026 7.983B
December 31, 2025 8.535B
September 30, 2025 10.08B
June 30, 2025 10.09B
March 31, 2025 9.760B
December 31, 2024 9.648B
September 30, 2024 11.20B
June 30, 2024 10.40B
March 31, 2024 10.64B
December 31, 2023 10.81B
September 30, 2023 10.76B
June 30, 2023 10.96B
March 31, 2023 10.95B
December 31, 2022 11.02B
September 30, 2022 10.68B
June 30, 2022 10.92B
March 31, 2022 10.39B
December 31, 2021 10.43B
September 30, 2021 10.92B
June 30, 2021 11.23B
March 31, 2021 11.32B
December 31, 2020 11.49B
September 30, 2020 11.58B
June 30, 2020 12.13B
Date Value
March 31, 2020 11.40B
December 31, 2019 11.30B
September 30, 2019 11.31B
June 30, 2019 11.43B
March 31, 2019 11.12B
December 31, 2018 10.98B
September 30, 2018 10.94B
June 30, 2018 11.23B
March 31, 2018 11.64B
December 31, 2017 11.63B
September 30, 2017 11.84B
June 30, 2017 11.79B
March 31, 2017 13.98B
December 31, 2016 13.87B
September 30, 2016 15.89B
June 30, 2016 18.29B
March 31, 2016 19.50B
December 31, 2015 19.39B
September 30, 2015 19.70B
June 30, 2015 19.72B
March 31, 2015 16.18B
June 30, 2014 13.88B
March 31, 2014 13.74B
December 31, 2013 13.71B
September 30, 2013 5.509B

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

View Total Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Assets (Quarterly) Benchmarks

View Total Assets (Quarterly) Benchmarks
Start Trial
Avadel Pharmaceuticals Plc 199.45M
Jazz Pharmaceuticals Plc 11.08B
GH Research Plc 372.35M
Cosmo NV --
Viatris, Inc. 35.04B

Total Assets (Quarterly) Related Metrics